Xeris Pharmaceuticals Inc reported $1.8M in Interest Expense on Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Acelrx Pharmaceuticals ACRX:US $ 538K 76K
Acura Pharmaceuticals ACUR:US 87K 26K
Eli Lilly And LLY:US $ 83.6M 3.3M
Endo International Ordinary Shares ENDP:US $ 142.99M 1.35M
JAZZ PHA JAZZ:US $ 93.47M 23.65M
Nektar Therapeutics NKTR:US $ 12.8M 0.29M
Pacira Pharmaceuticals PCRX:US $ 7.33M 0.31M
Supernus Pharmaceuticals SUPN:US $ 5.92M 1.43M
Teva Pharmaceutical Industries TEVA:US $ 232M 8M
Zogenix ZGNX:US $ 3.85M 0.06M